Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Deccan Health CareBOM:542248 -0.91%77 Days Inventory is 344.99 as of Mar. 2026, which is 34% below its 10-year median of 523.41. GuruFocus rates BOM:542248 with a GF Score™ of 77/100 and a GF Value™ of ₹26.15 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 922 Drug Manufacturers companies, Deccan Health Care ranks worse than 87.09% on this metric.
The historical rank and industry rank for Deccan Health Care's Days Inventory or its related term are showing as below:
BOM:542248'
s Days Inventory Range Over the Past 10 Years
Min: 237.51 Med: 523.41 Max: 1052.39
Current: 327.19
During the past 11 years, Deccan Health Care's highest Days Inventory was 1052.39. The lowest was 237.51. And the median was 523.41.
BOM:542248's Days Inventory is ranked worse than 87.09% of 922
companies
in the Drug Manufacturers industry
Industry Median: 165.005
vs BOM:542248: 327.19
Deccan Health Care's Days Inventory
increased
from Mar. 2025 (277.26) to Mar. 2026 (344.99).
It might indicate that Deccan Health Care's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Deccan Health Care's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.26.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Deccan Health Care's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 2.24.
Deccan Health Care (BOM:542248) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Deccan Health Care's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Deccan Health Care's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Deccan Health Care Days Inventory Related Terms
Deccan Health Care Days Inventory Historical Data
* Premium members only.
The historical data trend for Deccan Health Care's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Deccan Health Care's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Deccan Health Care Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Deccan Health Care's Days Inventory distribution charts can be found below:
* The bar in red indicates where Deccan Health Care's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Deccan Health Care (BOM:542248) has a Days Inventory of 344.99 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Deccan Health Care and its competitors. This is 34% below median its historical median of 523.41. Over the past decade, Deccan Health Care's Days Inventory has ranged from 237.51 to 1,052.39. According to the industry distribution chart, Deccan Health Care ranks #803 out of 922 companies in the Drug Manufacturers industry, placing it in the top 87.1%.
Is Deccan Health Care's Days Inventory too high?
Deccan Health Care's current Days Inventory of 344.99 is 34% below median its 10-year median of 523.41. Over the past 10 years, this metric has ranged from a low of 237.51 to a high of 1,052.39. The Drug Manufacturers industry median Days Inventory is 165.01. Deccan Health Care's value of 344.99 is 109.1% above this industry median. Based on the distribution chart, Deccan Health Care ranks #803 out of 922 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Deccan Health Care has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Deccan Health Care's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Deccan Health Care ranks #803 out of 922 companies for Days Inventory. This places Deccan Health Care in the lower half of its industry. The industry median Days Inventory is 165.01. Deccan Health Care's value of 344.99 is 109.1% above this benchmark. Historically, Deccan Health Care's own Days Inventory has ranged from 237.51 to 1,052.39 over the past decade. While the company's 10-year median is 523.41 vs. the industry median of 165.01, Deccan Health Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.01, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Deccan Health Care's current Days Inventory of 344.99 is 109.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Deccan Health Care and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Deccan Health Care's current Days Inventory is 344.99, which is 34% below median its own 10-year median of 523.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Deccan Health Care stock overvalued right now?
Based on GuruFocus' analysis, Deccan Health Care (BOM:542248) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹26.15, compared to a current price of ₹13.08 — trading 50% below its estimated fair value. The current Days Inventory is 344.99, which is 34% below median its 10-year median of 523.41 and 109.1% above the Drug Manufacturers industry median of 165.01. Deccan Health Care's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Deccan Health Care (BOM:542248), the current Days Inventory is 344.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Deccan Health Care (BOM:542248) Overvalued in 2026?
Based on GuruFocus' analysis, Deccan Health Care stock appears to be undervalued.
The current stock price of ₹13.08 is trading 50% below its estimated GF Value™ of ₹26.15.
GuruFocus considers Deccan Health Care to be Significantly Undervalued.
Key valuation signals for BOM:542248:
Days Inventory: 344.99 (34% below median its 10-year median of 523.41)
GF Value™: ₹26.15 vs. price of ₹13.08 (50% below fair value)
Industry Position: 109.1% above the Drug Manufacturers median (#803 of 922)
No single metric tells the full story. See the BOM:542248 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Deccan Health Care Ltd is into developing, manufacturing, and marketing a broad range of healthcare products, including nutraceutical, cosmeceutical, and ayurveda products (Fast Moving Consumer Health Products). Its products are Nutraceutical Food Products and other supplements and medicines. The company is operating in a single segment of manufacturing of nutraceutical products. The company operates in India as well as exports its products to other countries, and the majority of its revenue comes from India.
77GF Score
Get the complete analysis for BOM:542248
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542248 has been successfully added to your 
